Transplantation Market Size Worth $51.0 Billion By 2025 | CAGR: 9.1%: Grand View Research, Inc.

Tuesday, June 27, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

SAN FRANCISCO, June 27, 2017 /PRNewswire/ --

The global Transplantation Market is expected to reach

USD 51.0 billion by the year 2025, growing at a CAGR of 9.1%, according to a new report by Grand View Research, Inc. Growing incidence of organ failure has resulted in massive growth in the transplantation market. Rising demand for transplant
products such as tissue products, immunosuppressants, and organ preservation solutions is a major factor anticipated to boost growth of the market during forecast period. Thus, many biotechnology and medical device companies have begun to concentrate on the development of advanced transplant products for management of organ failure.

     (Logo:  )

Technological advancement in organ transplantation methods is another major factor supporting the market growth. The development of novel & improved transplant products such as tissue products  and surgical instruments has majorly contributed to the expansion of the sector. In addition, introduction of advanced tissue products such as DeNovo NT Graft, Chondrofix Osteochondral Allograft, and DuraMatrix Collagen Dura Substitute Membrane provides higher benefits during treatment.  In addition, computerized support systems with advanced systems and software allow easy & effective maintenance of tissues. Thus, availability of such advanced techniques supports increase in the number of organ transplant procedures.

Browse full research report with TOC on "Transplantation Market By Product (Tissue Products, Immunosuppressive Drugs, Preservation Solutions), By Application (Organ, Tissue Transplantation), By End-use, And Segment Forecasts, 2014 - 2025" at:

Further key findings from the report suggest: 

  • Tissue products segment was the largest revenue-generating amongst others due to escalating number of tissue and organ transplant procedures
  • Tissue products segment is also expected to grow at highest CAGR owing to advancement in transplantation products
  • Tissue transplant segment held the largest revenue share in the market, because of rising number of skin, bones, heart valves, cornea, tendons, nerves, and veins procedures worldwide
  • The transplant centers segment is projected to grow at the highest CAGR during the forecast period owing to rising popularity of these centers for transplant procedures
  • The hospitals segment dominated the market in terms of revenue in 2016 owing to a large number of transplant procedures performed in hospitals
  • North America was the leading regional sector in 2016 and is projected to maintain its dominance during the forecast period owing to well-developed healthcare infrastructure
  • Existence of large number of research laboratories, biotechnology, and medical device companies in the North America region is the major factor contributing to its large share
  • Some of the major players include AbbVie, Inc.; Arthrex, Inc.; Zimmer Biomet; Medtronic; Novartis AG; Stryker; 21st Century Medicine; BioLifeSolutions, Inc; Teva Pharmaceuticals; and Veloxis Pharmaceuticals.

Browse related reports by Grand View Research: 

  • Rubella Diagnostic Testing Market -
  • DNA Sequencing Market -
  • SNP Genotyping Market -
  • Apoptosis Market -

Grand View Research has segmented the global transplantation market on the basis of product, application, end-use, and region: 

  • Product Outlook (Revenue, USD Billion; 2014 - 2025) 
    • Tissue products
    • Immunosuppressive drugs
    • Preservation solutions
  • Application Outlook (Revenue, USD Billion; 2014 - 2025) 
    • Organ transplantation
    • Tissue transplantation
  • End-Use Outlook (Revenue, USD Billion; 2014 - 2025) 
    • Hospitals
    • Transplant centers
    • Others
  • Regional Outlook (Revenue, USD Billion; 2014 - 2025) 
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • UK
    • Asia Pacific
      • Japan
      • China
      • India
    • Latin America
      • Brazil
      • Mexico
    • MEA
      • South Africa

Read Our Blog:

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: +1-415-349-0058 Toll Free: +1-888-202-9519 Email:


SOURCE Grand View Research, Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store